Siga Technologies SIGA
NASDAQ SIGA
$3.09 -0.11 (-3.44%)
As of: Sep 9, 2026 · 3:59 PM EDT

Siga Technologies (SIGA) Research & Development (2010 - 2025)

Siga Technologies' (SIGA) quarterly Research & Development came in at $7.1 million in Q3 2025, up 133.22% on a YoY basis from $3.0 million in Q3 2024, and up 60.39% quarter-over-quarter from $4.4 million in Q2 2025.

Analysis

Siga Technologies (SIGA) Research & Development (2010 - 2025) Analysis & Trends

Siga Technologies (SIGA) has reported Research & Development for 16 consecutive years, with $7.1 million the latest figure, recorded in Q3 2025.

  • For the quarter ending Q3 2025, Research & Development rose 133.22% year-over-year to $7.1 million; the trailing twelve-month figure through Sep 2025 stood at $18.3 million (up 57.61% YoY), and the FY2024 full-year result was $12.3 million, down 25.06% from the prior year.
  • Research & Development improved to $7.1 million in Q3 2025 per SIGA's latest filing, from $4.4 million in the prior quarter.
  • Across five years, Research & Development topped out at $7.1 million in Q3 2025 and bottomed at $2.1 million in Q4 2021.
  • Historically, Research & Development has averaged $4.0 million across 5 years, with a median of $3.5 million in 2025.
  • The sharpest annual moves came in 2022 and 2023: Research & Development jumped 202.13% in 2022, then sank 59.14% in 2023.
  • Over 5 years, Research & Development stood at $2.1 million in 2021, then soared by 199.29% to $6.4 million in 2022, then tumbled by 59.14% to $2.6 million in 2023, then gained by 27.74% to $3.3 million in 2024, then surged by 110.95% to $7.1 million in 2025.
  • According to Business Quant data, Research & Development over the past three periods registered $7.1 million, $4.4 million, and $3.5 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn 3.65 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn 2.34 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn -2.85 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn 2.81 Bn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn -2.60 Bn
7 Revolution Medicines 43.79 Bn 43.79 Bn - 394.92 Mn
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 516.95 Mn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 146.30 Mn
10 Siga Technologies 220.19 Mn 65.22 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 7.05 Mn
Jun 30, 2025 4.40 Mn
Mar 31, 2025 3.46 Mn
Dec 31, 2024 3.34 Mn
Sep 30, 2024 3.02 Mn
Jun 30, 2024 2.89 Mn
Mar 31, 2024 3.05 Mn
Dec 31, 2023 2.62 Mn
Sep 30, 2023 3.65 Mn
Jun 30, 2023 5.12 Mn
Mar 31, 2023 5.05 Mn
Dec 31, 2022 6.41 Mn
Sep 30, 2022 5.73 Mn
Jun 30, 2022 6.84 Mn
Mar 31, 2022 3.55 Mn
Dec 31, 2021 2.14 Mn
Sep 30, 2021 3.24 Mn
Jun 30, 2021 2.26 Mn
Mar 31, 2021 2.30 Mn
Dec 31, 2020 3.01 Mn